Shell Sees LNG Trade Flat in 2026 as Hormuz Chokes Supply
Original Report
Shell Plc expects global liquefied natural gas supply to be flat year-on-year — after more than a decade of growth — as the conflict in the Middle East chokes supply.
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
Energy prices affect virtually every aspect of daily life—from commuting costs to heating bills to the price of groceries (which must be transported). For working families, energy represents one of the most volatile and impactful line items in their budgets. Energy policy decisions ripple through the economy, affecting everything from manufacturing competitiveness to household financial stress.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Stock futures inch higher after the Dow posts new record close: Live updates
Gains in Alphabet and a pause in U.S.-Iran hostilities boosted the Dow Industrials to its first close above 52,000 on Monday.
Inflation likely to stay ‘significantly above target,’ top European central banker warns
Joachim Nagel, president of Germany’s Bundesbank, spoke to CNBC on the sidelines of an ECB conference in Portugal.
Yen Under Pressure: 3-Minutes MLIV
Anna Edwards, Guy Johnson, Tom Mackenzie and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade." (Source: Bloomberg)
French biotech stock soars 31% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.